Key Takeaways
- Atlassian (TEAM) reached a 52-week peak of $198.60, marking a remarkable 165% surge over the last six months.
- Fourth-quarter adjusted earnings per share of $1.87 exceeded analyst projections of $1.50; sales of $1.77 billion surpassed the $1.66 billion forecast.
- Cloud segment revenue climbed 31% annually to $1.21 billion; deferred revenue obligations jumped 44% to $4.8 billion.
- BTIG reaffirmed its Buy recommendation with a $230 target price, designating Atlassian as its preferred sector investment.
- A total of 21 Wall Street analysts have increased their profit projections, with several investment firms elevating their targets after impressive Q4 performance.
Atlassian achieved a 52-week peak of $198.60 during this week’s trading sessions, with shares hovering around $198.77. This represents an impressive gain of approximately 165% across the previous six-month period.
The impressive rally follows robust fiscal Q4 performance metrics. The enterprise software company delivered adjusted earnings of $1.87 per share, significantly exceeding the Street’s $1.50 projection. Total sales reached $1.77 billion, surpassing analyst forecasts of $1.66 billion while representing 28% annual expansion.
The cloud business segment emerged as a particularly bright spot, gaining momentum with 31% growth to reach $1.21 billion. Deferred performance obligations climbed 44% to $4.8 billion, signaling robust future revenue visibility.
Additionally, the company achieved its first positive GAAP operating income in more than two years, delivering a 12% margin. This operational milestone captured considerable attention from the investment community.
Wall Street Increases Price Projections
Several investment firms elevated their price objectives after reviewing the quarterly results. BTIG maintained its Buy recommendation while establishing a $230 price objective, emphasizing Atlassian’s ability to command premium pricing and capitalize on artificial intelligence monetization opportunities. The research firm designated Atlassian as its premier selection within the software sector.
Cantor Fitzgerald also established a $220 objective, expressing conviction in sustained cloud expansion and AI-powered growth catalysts. Bank of America elevated the stock to Buy status while increasing its target to $175. FBN Securities adjusted its objective to $170 from $110, while preserving an Outperform recommendation.
TD Cowen modified its target to $145 and noted the chief executive’s $250 million share repurchase program as a contributing factor in the investment thesis.
Collectively, 21 Wall Street analysts have lifted their profit forecasts in advance of the upcoming earnings release.
Future Growth Catalysts
BTIG identified several specific growth drivers in research commentary published after discussions with Atlassian’s executive team. The company’s fiscal 2027 Cloud revenue growth projection stands 350 basis points higher than the previous year’s initial forecast.
The Collections capability, scheduled for December 3, 2026 rollout, incorporates 10 times more Rovo Credits compared to earlier product offerings. BTIG’s internal examination of Atlassian’s pricing tools indicates potential for customer expenditures to multiply significantly across numerous scenarios.
Atlassian serves approximately 85% of Fortune 500 companies, though these enterprise clients represent merely 10% of total revenue. Average yearly expenditure per enterprise account stands at roughly $1.5 million, which Wall Street views as substantial expansion opportunity.
Organizations utilizing both Jira and Confluence products who transition to Team Anywhere Contracts generally experience pricing increases in the mid-teens percentage range.
BTIG anticipates Rovo Credits will emerge as a more significant revenue contributor during fiscal 2028 rather than fiscal 2027. The research firm projects approximately 100 basis points of inorganic revenue contribution from the DX acquisition this year, with remaining growth powered by user expansion and product cross-selling initiatives.
InvestingPro’s Fair Value analysis currently indicates the stock remains modestly undervalued at present trading levels.



